Indications and uses
For the prevention and treatment of these symptoms associated with motion sickness • nausea • vomiting • dizziness
For the prevention and treatment of these symptoms associated with motion sickness • nausea • vomiting • dizziness
take the first dose 1/2 hour to 1 hour before starting activity Adults and children 12 years of age and over: Take 1 to 2 tablets once daily, or as directed by a doctor Do not exceed 2 tablets in 24 hours.
• TAMPER EVIDENT: Do not use if imprinted seal under cap is broken or missing. • store at 20-25ºC (68-77ºF); excursions permitted between 15º-30ºC (59º-86ºF) • protect from humidity
Meclizine HCI 25mg
Antiemetic
For the prevention and treatment of these symptoms associated with motion sickness • nausea • vomiting • dizziness
Do not use in children under 12 years of age unless directed by a doctor.
Ask a doctor before use if you have
• breathing problems, such as emphysema or chronic bronchitis
• glaucoma
• difficulty urinating due to an enlarged prostate gland
A sk a doctor or pharmacist before use if you are taking sedatives or tranquilizers.
When using this product
• drowsiness may occur
• avoid alcoholic beverages
• alcohol, sedatives and tranquilizers may increase drowsiness
• use caution when driving a motor vehicle or operating machinery
I
f
pregnant or breast-feeding,ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Take 1 to 2 tablets once daily, or as directed by a doctor
Do not exceed 2 tablets in 24 hours.
• TAMPER EVIDENT:Do not use if imprinted seal under cap is broken or missing.
• store at 20-25ºC (68-77ºF); excursions permitted between 15º-30ºC (59º-86ºF)
• protect from humidity
colloidal silicon dioxide, D&C yellow #10 lake, lactose monohydrate, magnesium stearate, pregelatinized starch.
1-800-540-3765
| Class | Version | Type | Effective |
|---|---|---|---|
| MECLIZINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| ac6963c4-31c6-325f-ee58-83a0a06597ad | Product name | 5 | 20221206 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80136-378-01 | Meclizine Hydrochloride | 100 in 1 BOTTLE | TABLET | 100 | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 80136-378 | 80136-378-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| LACTOSE MONOHYDRATE | EWQ57Q8I5X | IACT |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| STARCH, CORN | O8232NY3SJ | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| D&C YELLOW NO. 10 ALUMINUM LAKE | CQ3XH3DET6 | IACT |
| MECLIZINE HYDROCHLORIDE | HDP7W44CIO | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 0a20bfde-2901-285a-e063-6394a90a02b8 | e3c73fdc-670d-118f-e053-2a95a90a954c | 2023-11-14 | Warnings | 0a20bfde-2901-285a-e063-6394a90a02b8 e3c73fdc-670d-118f-e053-2a95a90a954c |
Adverse event summaries are temporarily unavailable. Other product information remains available.